The Jikei University School of Medicine · Graduate School of Medicine / Faculty of Medicine

Research keywordsprostate cancer・brachytherapy・androgen deprivation・urothelial carcinoma・PSMA PET・renal cell carcinoma

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy.
• Reply to Cengiz Beyan and Esin Beyan. Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 97(2), 3-4, 2020.
• Correction to: Comparison of outcomes in high‑risk prostate cancer patients treated with low‑/high‑dose‑rate brachytherapy plus external beam radiotherapy.
• [RISK FACTORS FOR INTRAVESICAL RECURRENCE AFTER SURGICAL MANAGEMENT OF UROTHERIAL CARCINOMA OF THE UPPER URINARY TRACT].

• Official profile